Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear receptor corepressor 2 | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | nuclear receptor subfamily 2, group E, member 3 | Starlite/ChEMBL | No references |
Homo sapiens | peroxisome proliferator-activated receptor gamma | No references | |
Homo sapiens | Niemann-Pick disease, type C1 | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | RAB9A, member RAS oncogene family | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | nuclear receptor subfamily 2, group E, member 3 | 410 aa | 384 aa | 28.1 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Plasmodium falciparum | ras-related protein Rab-5B | RAB9A, member RAS oncogene family | 201 aa | 165 aa | 30.9 % |
Echinococcus granulosus | ecdysone induced protein 78C | peroxisome proliferator-activated receptor gamma | 477 aa | 447 aa | 28.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0035 | 0.0115 |
Schistosoma mansoni | hypothetical protein | 0.0055 | 0.0158 | 0.0905 |
Echinococcus multilocularis | expressed conserved protein | 0.0112 | 0.0761 | 0.0761 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.2618 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.012 | 0.0854 | 0.2814 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0035 | 0.02 |
Echinococcus multilocularis | nuclear receptor co repressor related (ncor) | 0.0333 | 0.3115 | 0.3115 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0035 | 0.0115 |
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0.0035 | 0.5 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0051 | 0.0115 | 0.038 |
Loa Loa (eye worm) | hypothetical protein | 0.0325 | 0.3036 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0035 | 0.5 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.017 | 0.1381 | 0.1381 |
Onchocerca volvulus | 0.0043 | 0.0035 | 0.0134 | |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.2248 | 0.7406 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.0238 | 0.0783 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0035 | 0.5 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0325 | 0.3036 | 1 |
Echinococcus granulosus | nuclear receptor co repressor related ncor | 0.0333 | 0.3115 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.0035 | 0.5 |
Echinococcus multilocularis | protein dispatched 1 | 0.0058 | 0.0192 | 0.0192 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1751 | 1 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0121 | 0.0858 | 0.4898 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.0096 | 0.0547 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0043 | 0.0035 | 0.0115 |
Loa Loa (eye worm) | hypothetical protein | 0.0119 | 0.0838 | 0.2761 |
Entamoeba histolytica | Niemann-Pick C1 protein, putative | 0.0119 | 0.0838 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0115 | 0.038 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0051 | 0.0115 | 0.037 |
Onchocerca volvulus | 0.0043 | 0.0035 | 0.0134 | |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.0096 | 0.0547 |
Echinococcus multilocularis | protein patched | 0.0051 | 0.0115 | 0.0115 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.017 | 0.1381 | 0.4434 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1751 | 0.1751 |
Mycobacterium leprae | conserved hypothetical protein | 0.0043 | 0.0035 | 0.5 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0119 | 0.0838 | 0.269 |
Brugia malayi | beta-lactamase | 0.0043 | 0.0035 | 0.0115 |
Loa Loa (eye worm) | beta-lactamase | 0.0043 | 0.0035 | 0.0115 |
Brugia malayi | CHE-14 protein | 0.0051 | 0.0115 | 0.038 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0035 | 0.0115 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.0096 | 0.0547 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0043 | 0.0035 | 0.0112 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.253 | 1 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0051 | 0.0115 | 0.0115 |
Brugia malayi | Niemann-Pick C1 protein precursor | 0.0119 | 0.0838 | 0.2761 |
Echinococcus granulosus | Protein patched homolog 1 | 0.0051 | 0.0115 | 0.037 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.012 | 0.0854 | 0.2814 |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.0035 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0035 | 0.0115 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0119 | 0.0838 | 0.0838 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0043 | 0.0035 | 0.0035 |
Echinococcus granulosus | expressed conserved protein | 0.0112 | 0.0761 | 0.2444 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.012 | 0.0854 | 0.2814 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0854 | 0.2814 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.0035 | 0.0115 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0035 | 0.0115 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0.0035 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0082 | 0.0448 | 0.1477 |
Onchocerca volvulus | 0.0286 | 0.2618 | 1 | |
Onchocerca volvulus | 0.0043 | 0.0035 | 0.0134 | |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0.0035 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.0448 | 0.1477 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0.0035 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.0448 | 0.2561 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1751 | 1 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0035 | 0.0115 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.2248 | 0.7406 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.0035 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0035 | 0.02 |
Schistosoma mansoni | patched 1 | 0.0051 | 0.0115 | 0.0659 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.0096 | 0.0547 |
Mycobacterium leprae | Probable lipase LipE | 0.0043 | 0.0035 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 0.0115 | 0.0311 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0035 | 0.0115 |
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0.0035 | 0.5 |
Echinococcus granulosus | geminin | 0.0205 | 0.1751 | 0.5621 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0035 | 0.0115 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0.0035 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 6.809 um | PUBCHEM_BIOASSAY: TR-FRET-based biochemical high throughput dose response assay to identify NR2E3 inverse agonists. (Class of assay: confirmatory) [Related pubchem assays: 2379 (Confirmation (NR2E3 agonists in quadruplicate)), 2759 (Dose response counterscreen (PPARg and NCOR2 interaction agonists in triplicate)), 2758 (Dose response (NR2E3 agonists in quadruplicate)), 2325 (Summary (NR2E3 agonists)), 2300 (Primary screen (NR2E3 agonists in singlicate))] | ChEMBL. | No reference |
IC50 (functional) | = 7.18 um | PUBCHEM_BIOASSAY: Counterscreen for NR2E3 inverse agonists: TR-FRET-based biochemical high throughput dose response assay to identify inverse agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2). (Class of assay: confirmatory) [Related pubchem assays: 2379 (Confirmation (NR2E3 agonists in quadruplicate)), 2759 (Dose response counterscreen (PPARg and NCOR2 interaction agonists in triplicate)), 2758 (Dose response (NR2E3 agonists in quadruplicate)), 2325 (Summary (NR2E3 agonists)), 2300 (Primary screen (NR2E3 agonists in singlicate))] | ChEMBL. | No reference |
Potency (functional) | 1.7783 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 2.8184 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 2.8184 um | PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 3.9811 um | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 21.3313 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 23.0999 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.